User login
Dr. Marc Klapholz of Rutgers University, Newark, N.J., explains the latest developments in portopulmonary arterial hypertension, hepatopulmonary syndrome, and cirrhotic cardiomyopathy, as well as the emerging field and association between non-alcoholic fatty liver disease and cardiovascular disease.
Dr. Marc Klapholz of Rutgers University, Newark, N.J., explains the latest developments in portopulmonary arterial hypertension, hepatopulmonary syndrome, and cirrhotic cardiomyopathy, as well as the emerging field and association between non-alcoholic fatty liver disease and cardiovascular disease.
Dr. Marc Klapholz of Rutgers University, Newark, N.J., explains the latest developments in portopulmonary arterial hypertension, hepatopulmonary syndrome, and cirrhotic cardiomyopathy, as well as the emerging field and association between non-alcoholic fatty liver disease and cardiovascular disease.
AT DIGESTIVE DISEASES: NEW ADVANCES
